首页> 外国专利> Compound 3 - 1 - (1 - methyl - 3 - trifluoromethyl - pyridin-3-yl) ethylamino - 5 - (3 - trifluorometoxifenil) - 1 - 4 - (trifluoromethyl) - phenyl) - pyrrolidin-2-one; and use for the treatment of a disorder selected ObesDery, Schizophrenia, Substance Abuse, or depends on

Compound 3 - 1 - (1 - methyl - 3 - trifluoromethyl - pyridin-3-yl) ethylamino - 5 - (3 - trifluorometoxifenil) - 1 - 4 - (trifluoromethyl) - phenyl) - pyrrolidin-2-one; and use for the treatment of a disorder selected ObesDery, Schizophrenia, Substance Abuse, or depends on

机译:化合物3- [1-(1-甲基-3-三氟甲基-吡啶-3-基)乙氨基] -5-(3-三氟甲氧芬太尼)-1- [4-(三氟甲基)-苯基)-吡咯烷-2-一;和用于治疗肥胖症,精神分裂症,药物滥用的疾病,或取决于

摘要

Compounds and pharmaceutical compositions comprising compounds of the Formula as CB1 receptor inverse agonists useful for reducing body weight in mammals, treating cognitive impairment associated with schizophrenia, and mitigating treatment emergent weight gain observed during treatment with antipsychotics.
机译:化合物和药物组合物,其包含作为下式化合物的CB1受体反向激动剂,可用于降低哺乳动物的体重,治疗与精神分裂症相关的认知障碍以及减轻在用抗精神病药治疗期间观察到的治疗体重增加。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号